Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity

Description

The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.

Conditions

Dentin Hypersensitivity

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.

A Randomized, Double-blinded, Placebo-controlled, Phase 2 Study to Assess the Efficacy and Safety of Three Topical Applications of KH001 in Providing Long-term Relief from Dentin Hypersensitivity

Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity

Condition
Dentin Hypersensitivity
Intervention / Treatment

-

Contacts and Locations

Cambridge

ADA Forsyth, Cambridge, Massachusetts, United States, 02142

Cambridge

Forsyth Institute, Cambridge, Massachusetts, United States, 02142

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Is at least 18 years old by the time of the screening visit
  • * Is in good general health as determined by the investigator
  • * Has at least 2 non-adjacent teeth and is diagnosed with hypersensitive
  • * Is allergic to the active drug substance or other excipients used in the investigational product
  • * Has any history of alcohol or drug abuse
  • * Has received any treatment related to dentin hypersensitivity within 8 weeks prior to the screening visit
  • * Is jedged by the investigator as ineligible for participation for other reasons

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

HysensBio Co., Ltd,

Hatice Hasturk, PRINCIPAL_INVESTIGATOR, ADA Forsyth

Study Record Dates

2025-06-30